GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for maleylacetate reductase (Q93T12)

Analyse AlphaFold monomer V2.0 prediction for maleylacetate reductase (Q93T12) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q93T12
Type
protein
Length
352 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xBc0D917FA4795675935BEf33e3A0671BBDb3ebf1
Molecule
Maleylacetate reductase
UniProt
Q93T12
Pockets
1 · best druggability 0.75

Structure

1 distinct chain · 58% helix, 12% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMaleylacetate reductaseprotein35258% helix, 12% strandQ93T12

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17270.750.8063empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.